Unity's Q2 FY25 results reveal AI-driven growth, but competition and high valuation raise risks. Click here to find out why I ...

Unity Biotechnology and Mammoth Biosciences are both turning toward cost-saving measures, prompting layoffs at both companies. Unity’s restructuring comes along with 36-week results from its phase 2b ...